Trial intelligence / Profile preview

PICCOLA: Pioglitazone on Cardiac Function

NCT00485056Phase 4Completed

Sponsor
Imperial College London
Start
Apr 2008
Primary completion
Apr 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Imperial College London. Started Apr 2008; status: completed.

02

Drugs

pioglitazone
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00485056.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00485056.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call